BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4584486)

  • 21. Phase II trial of iv 6-thioguanine in advanced colorectal carcinoma.
    Britell JC; Moertel CG; Kvols LK; O'Connell MJ; Rubin J; Schutt AJ
    Cancer Treat Rep; 1981; 65(9-10):909-10. PubMed ID: 7273027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of ICRF-159 (NSC-129943) in advanced colorectal carcinoma.
    Marciniak TA; Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
    Cancer Chemother Rep; 1975; 59(4):761-3. PubMed ID: 1100228
    [No Abstract]   [Full Text] [Related]  

  • 23. Combination chemotherapy of cisplatin and 5-FU in advanced colorectal carcinoma.
    Dy C; Gil A; Algarra SM; Aparicio LA; Calvo F; Herranz P
    Cancer Treat Rep; 1986 Apr; 70(4):465-8. PubMed ID: 3698039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II evaluation of DON (6-diazo-5-oxo-L-norleucine) in patients with advanced colorectal carcinoma.
    Lynch G; Kemeny N; Casper E
    Am J Clin Oncol; 1982 Oct; 5(5):541-3. PubMed ID: 7180833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination chemothereapy with cis-diamminedichloroplatinum (II) and bleomycin in tumors of the head and neck.
    Wittes RE; Brescia F; Young CW; Magill GB; Golbey RB; Krakoff IH
    Oncology; 1975; 32(5-6):202-7. PubMed ID: 59332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose intermittent iv 5-FU and melphalan in advanced colorectal carcinoma.
    Gough IR; Furnival CM
    Cancer Treat Rep; 1983 Jun; 67(6):595-6. PubMed ID: 6344994
    [No Abstract]   [Full Text] [Related]  

  • 27. Continuous-infusion cisplatin and bolus 5-fluorouracil in colorectal carcinoma.
    Posner MR; Belliveau JF; Weitberg AB; Sabbath K; Wiemann MC; Cummings FJ; Calabresi P
    Cancer Treat Rep; 1987 Oct; 71(10):975-7. PubMed ID: 3308082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of a combination of cyclosphamide, vincristine, and methotrexate in advanced colorectal carcinoma.
    Taylor SG; Desai SA; DeWys WD
    Cancer Treat Rep; 1978 Aug; 62(8):1203-5. PubMed ID: 356978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A clinical study (phase II) of a combination of 5-fluorouracil, vincristine and methyl CCNU in patients with advanced carcinoma of the large intestine].
    Roth A; Kolarić K
    Lijec Vjesn; 1983 Jun; 105(6):244-6. PubMed ID: 6633141
    [No Abstract]   [Full Text] [Related]  

  • 30. [Results of treatment with 5-fluorouracil and folinic acid in patients with carcinoma of the large intestine].
    Nastasi G; Sala L; Romano AM; Nucera D; Anselmetti L; Castoldi O; Crema F; Pasotti D
    Medicina (Firenze); 1988; 8(2):175-8. PubMed ID: 2852292
    [No Abstract]   [Full Text] [Related]  

  • 31. Phase II study of metronidazole therapy for advanced colorectal carcinoma.
    Frytak S; Moertel CG; Childs DS; Schutt AJ; Albers JW
    Cancer Treat Rep; 1978 Mar; 62(3):483-5. PubMed ID: 348320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.
    Michaelson R; Kemeny N; Young C
    Cancer Treat Rep; 1982 Sep; 66(9):1757-8. PubMed ID: 6956441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized comparison of melphalan and 5-fluorouracil in the treatment of advanced gastrointestinal cancer.
    Bullen BR; Giles GR; Malhotra A; Bird GG; Hall R; Bunch GA; Brown GJ
    Cancer Treat Rep; 1976 Sep; 60(9):1267-71. PubMed ID: 797448
    [No Abstract]   [Full Text] [Related]  

  • 34. Adriamycin (NSC-123127) therapy for advanced gastrointestinal cancer.
    Frytak S; Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
    Cancer Chemother Rep; 1975; 59(2 Pt 1):405-9. PubMed ID: 1097099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current protocol approaches in large bowel cancer.
    Carter SK
    Semin Oncol; 1976 Dec; 3(4):433-43. PubMed ID: 793018
    [No Abstract]   [Full Text] [Related]  

  • 36. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU.
    Macdonald JS; Kisner DF; Smythe T; Woolley PV; Smith L; Schein PS
    Cancer Treat Rep; 1976 Nov; 60(11):1597-600. PubMed ID: 1021233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II clinical trial of ftorafur in 5-fluorouracil-refractory colorectal cancer.
    Buroker T; Miller A; Baker L; McKenzie M; Samson M; Vaitkevicius VK
    Cancer Treat Rep; 1977 Nov; 61(8):1579-80. PubMed ID: 336199
    [No Abstract]   [Full Text] [Related]  

  • 38. [Combination chemotherapy of cis-diamminedichloroplatinum (CDDP) and 5-fluorouracil (5-FU) in gastrointestinal tumors].
    Yamazaki H; Ogawa M; Horikoshi N; Inoue K; Nakamura T; Ueno K; Ito Y; Imajo K; Mukaiyama T; Miyaoka K
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2568-72. PubMed ID: 3017230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [cis-Dichlorodiammine platinum (II) in the treatment of advanced colo-rectal cancer].
    Dozono H; Moriya Y; Saijo N; Fujita J; Koyama Y
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1465-9. PubMed ID: 2990351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraluminal fluorouracil chemotherapy adjunct to surgical procedures for respectable carcinoma of the colon and rectum.
    Grossi CE; Wolff WI; Nealon TF; Pasternack B; Ginzburg L; Rousselot LM
    Surg Gynecol Obstet; 1977 Oct; 145(4):549-54. PubMed ID: 331522
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.